Ibuprofen Aflofarm 200 mg
Ibuprofen Aflofarm 200 mg to tabletki drażowane wskazane do stosowania w:
- moderate to mild pains: toothache, arthralgia, myalgia, dysmenorrhea, headache (including migraine headaches);
- pain associated with flu and cold;
- feverish conditions of various origins (including influenza, colds or other infectious diseases).
Pharmaceutical form diced tablets. 200 mg - 20 tab.
Pharmaceutical form diced tablets. 200 mg - 10 tab.
Category OTC
Additional information
Dosage and administration: Oral use.
Adults and children over 12 years of age: initial dose of 1 to 2 tablets, then 1 to 2 tablets every 4 to 6 hours, if necessary. Do not use more than 6 tablets (1200 mg of ibuprofen) per day. The tablets should be taken with water.
The medicinal product is intended for emergency use. Undesirable effects may be reduced by using the lowest effective dose for the shortest duration necessary to alleviate symptoms.
The medicinal product is not indicated for children under 12 years of age. Elderly: no dose adjustment is required.
Active substance
1 tablet contains 200 mg of ibuprofen (Ibuprofenum). Excipient with known effect: sucrose.
Indications
- moderate to mild pains: toothache, arthralgia, myalgia, dysmenorrhea, headache (including migraine headaches);
- pain associated with flu and cold;
- feverish conditions of various origins (including influenza, colds or other infectious diseases)
Contraindications
The medicinal product should not be used in patients:
- with hypersensitivity towards the active substance, any excipient and other non-steroidal anti-inflammatory drugs (NSAIDs);
- who have a history of allergy such as rhinitis, urticaria or bronchial asthma after taking acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs);
- with a history of stomach ulcer and/or active duodenal ulcer, or history of perforation or bleeding, also associated with the use of NSAIDs
- with severe hepatic insufficiency, severe renal insufficiency or severe heart failure (NYHA class IV);
- History of bronchial asthma, urticaria or allergic reaction after taking acetylsalicylic acid or other NSAIDs.
- taking other NSAIDs, including COX-2 inhibitors, at the same time (increased risk of side effects)
- during the third trimester of pregnancy
- with hemorrhagic diathesis
Marketing Authorisation Holder
Aflofarm Farmacja Polska Spółka z o.o.
Marketing Authorisation
14214
Information for the patient
Read the package leaflet for indications, contraindications, side effects, dosage as well as information on the use of this product, or consult your doctor or pharmacist before use. Misusing medicines may be dangerous to your life or health.
See how we care about quality
All our products are subject to strict safety requirements
We use rigorous quality control standards and procedures to ensure the highest level of safety for all our products.
See how we care about safety